Quick Answer
Citius Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $4.25 million for the year ending 2025.
- Citius Pharmaceuticals, Inc. showed an increase of +30.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Citius Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2010 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $4.25 million | Fiscal year 2024: $3.25 million | Fiscal year 2023: $26.48 million | Fiscal year 2022: $41.71 million | Fiscal year 2021: $70.07 million | Fiscal year 2020: $13.86 million | Fiscal year 2019: $7.89 million | Fiscal year 2018: $9.18 million | Fiscal year 2017: $3.20 million | Fiscal year 2016: $294.4 thousand | Fiscal year 2016: $1.63 million | Fiscal year 2015: $676.1 thousand | Fiscal year 2014: $1.55 million | Fiscal year 2013: $54.4 thousand | Fiscal year 2013: $0.00 | Fiscal year 2012: $41.7 thousand | Fiscal year 2012: $135.00 | Fiscal year 2011: $212.00 | Fiscal year 2010: $2.5 thousand | Fiscal year 2010: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: